These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14751142)

  • 41. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
    Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
    Inuzuka K; Ogata Y; Nagase H; Shirouzu K
    J Surg Res; 2000 Oct; 93(2):211-8. PubMed ID: 11027463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis.
    Kim TJ; Rho SB; Choi YL; Choi CH; Lee JW; Bae DS; Ahn G; Lee JH; Kim BG
    Hum Pathol; 2006 Jul; 37(7):906-13. PubMed ID: 16784992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 45. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
    Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors.
    van der Burg ME; Henzen-Logmans SC; Berns EM; van Putten WL; Klijn JG; Foekens JA
    Int J Cancer; 1996 Dec; 69(6):475-9. PubMed ID: 8980250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
    Saito S; Zempo N; Yamashita A; Takenaka H; Fujioka K; Esato K
    Vasc Endovascular Surg; 2002; 36(1):1-7. PubMed ID: 12704518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
    Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
    Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
    Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.
    Yang WL; Godwin AK; Xu XX
    Cancer Res; 2004 Feb; 64(4):1534-40. PubMed ID: 14973065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de e Nictolis M; Garbisa S; Masiero L; Romanini C; Graziella B
    Anticancer Res; 1995; 15(6B):2799-804. PubMed ID: 8669868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.
    Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y
    Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin-1 promotes proteolytic activity of ovarian carcinoma.
    Rosanò L; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():306S-309S. PubMed ID: 12193110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Meade-Tollin LC; Way D; Witte MH
    Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.